SkyePharma to Present at the Deutsche Bank European Healthcare, Specialty Pharma and Biotech Conference

SkyePharma to Present at the Deutsche Bank European Healthcare,
Specialty Pharma and Biotech Conference 


LONDON, June 10  /PRNewswire-FirstCall/ -- SkyePharma PLC (LSE:SKPLSE:
Nasdaq:LSE:SKYE) announces today that the Company's Chief Executive Officer,
Michael Ashton, will make a presentation at the Deutsche Bank European
Healthcare, Specialty Pharma and Biotech Conference on Thursday, June 17th,
2004 at 09:15 a.m. (BST) in London.  The presentation will not be webcast but
will be recorded by video and a PDF of the presentation will be posted on the
conference website at the end of the meeting. For the slides of this
presentation, please visit SkyePharma's website http://www.skyepharma.com/
under Investor Relations / Presentations.

About SkyePharma

SkyePharma develops pharmaceutical products benefiting from world-leading drug
delivery technologies that provide easier-to-use and more effective drug
formulations. There are now ten approved products incorporating SkyePharma's
technologies in the areas of oral, injectable, inhaled and topical delivery,
supported by advanced solubilisation capabilities. For more information, visit
http://www.skyepharma.com/ .

  For further information please contact:
   SkyePharma PLC                                     [phone]
   Michael Ashton, Chief Executive Officer
   Peter Laing, Director of Corporate Communications  [phone]
   Sandra Haughton, US Investor Relations              [phone]

   Buchanan Communications                            [phone]
   Tim Anderson / Mark Court


DATASOURCE: SkyePharma PLC



CONTACT:  Michael Ashton, Chief Executive Officer, Peter Laing, Director

of Corporate Communications, [phone], or Sandra Haughton, US Investor

Relations, [phone], all of SkyePharma PLC, [phone]; or Tim

Anderson, or Mark Court, both of Buchanan Communications, [phone],

for SkyePharma PLC



Web site:  http://www.skyepharma.com/ 

Copyright